Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy
=====================================================================================================================================================================

* Grace Heloise Attrill
* Carina N Owen
* Tasnia Ahmed
* Ismael A Vergara
* Andrew J Colebatch
* Jordan W Conway
* Kazi J Nahar
* John F Thompson
* Ines Pires da Silva
* Matteo S Carlino
* Alexander M Menzies
* Serigne Lo
* Umaimainthan Palendira
* Richard A Scolyer
* Georgina V Long
* James S Wilmott